Follow Us:
Thursday, December 05, 2019

johnson and johnson

JOHNSON AND JOHNSON NEWS

Johnson & Johnson loses pelvic mesh class action in Australia

November 21, 2019 11:32 am

Australia's Federal Court found that J&J subsidiary Ethicon had sold the devices without warning women about the "gravity of the risks", and was negligent in rushing the products to market before proper testing.

Johnson & Johnson says new tests find no asbestos in recalled baby powder

October 30, 2019 7:29 am

Johnson & Johnson said the tests covered the bottle previously tested by the FDA and other samples from the same lot that was recalled.

Johnson & Johnson to recall single lot of baby powder as FDA finds traces of asbestos in US

October 18, 2019 7:43 pm

The company's shares fell 2 per cent to $133.01 in premarket trade. J&J also said it has started an investigation and is working with health regulators to determine the integrity of the tested sample as well as the validity of test results.

Johnson & Johnson directed to pay $8 billion after man complains of breast growth

October 09, 2019 4:54 pm

Nicholas Murray, a Maryland resident, in his lawsuit, has alleged that after taking their drug Risperdal from 2003 to 2008, he developed gynecomastia, a condition that caused him to grow breasts.

Jury says Johnson & Johnson must pay $8 billion in case over male breast growth

October 09, 2019 9:04 am

J&J said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it will be overturned." It added that the jury in the case had not been allowed to hear evidence of Risperdal's benefits.

Patients and victims

July 29, 2019 7:40 am

Investigations into faulty hip implants highlight the urgent need for a law to regulate medical devices.

Johnson & Johnson says no suffering patients in India. Meet some of them

July 27, 2019 8:17 am

Investigating the patients' records paints a story of suffering, neglect and indifference. Of them hitting a wall when it comes to seeking justice even as they fight debilitating pain, organ damage, pseudo-tumours, the toxic effects of excess cobalt-chromium in the blood.

In US, Johnson & Johnson agrees to pay $1 billion for faulty hip implants, in India brazens it out

July 27, 2019 8:15 am

Johnson & Johnson has claimed in India that it has received no adverse event reports on Pinnacle. Medical records accessed by The Indian Express show otherwise.

J&J faulty implants case: 67 people to get Rs 25 lakh each

May 31, 2019 12:51 am

The company told Justice Vibhu Bakhru that though the Central government has given a list of 93 people affected, J&J authorities were able to verify documents of only 67 claimants.

For now, pay Rs 25 lakh each in 4 faulty hip implant cases, HC tells J&J

May 03, 2019 3:54 am

The interim order came after J&J volunteered to pay Rs 25 lakh as compensation to the affected patients.